Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.6 USD | +0.49% | -1.48% | -2.25% |
Apr. 23 | Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126 | MT |
Apr. 22 | Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating | MT |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.75B | Capitalization | 187B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.17B | EV / Sales 2024 * | 4.61 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 913M | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
31.4
x | P/E ratio 2025 * |
26.8
x | Employees | 114,000 |
Yield 2024 * |
2.01% | Yield 2025 * |
2.15% | Free-Float | 86.77% |
Latest transcript on Abbott Laboratories
1 day | +0.49% | ||
1 week | -1.48% | ||
Current month | -5.34% | ||
1 month | -2.70% | ||
3 months | -5.62% | ||
6 months | +12.33% | ||
Current year | -2.25% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +4.24% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 107.6 | +0.49% | 3,849,589 |
24-04-22 | 107.1 | -0.20% | 4,948,315 |
24-04-19 | 107.3 | +1.91% | 10,533,616 |
24-04-18 | 105.3 | -0.59% | 7,306,449 |
24-04-17 | 105.9 | -3.03% | 12,002,886 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.25% | 187B | |
-1.32% | 108B | |
-3.92% | 67.71B | |
+7.99% | 53.07B | |
+15.74% | 47.36B | |
+6.01% | 39.73B | |
+10.81% | 28.56B | |
+2.34% | 26.55B | |
+15.97% | 25.13B | |
-0.16% | 24.97B |
- Stock Market
- Equities
- ABT Stock